Chagas Disease: Where to now?

Louise Gabrielle Shewan, Andrew Coats, Michael Henein, Reinaldo Bestetti


This special issue includes expert reviews on the neglected cardiological syndrome – Chagas Disease (CD), also known as American trypanosomiasis.   First described in 1909 this syndrome is endemic in several Latin American countries. This specially commissioned themed issue of the International Cardiovascular Forum Journal brings together notable experts who discuss a wide range of emerging topics in CD.  These include the changing, and challenging, epidemiology of CD in migrants and visitors to the Europe and the USA.  We also review what treatments exist for the primary infective aetiology, and how to manage Chagas cardiomyopathy when it has reached its end-stage heart failure form.  We have expert reviews on advanced imaging techniques and their role in the assessment and care of Chagas’ patients and the opportunity to protect against sudden death in this enigmatic condition.  


Chagas Disease; Review

Full Text:



Tibayrenc M, Telleria J. 2010. American trypanosomiasis: Chagas disease: one hundred years of research, 1st edn. Elsevier insights. Elsevier: London; Burlington, MA, USA, 848 p.

Makik LH, Singh GD, Amsterdam EA, et al. Chagas Heart Disease: An Update. Am J Med. 2015. Nov; 128(11):1251.e7-9. DOI:

Pinazo MJ, Gascon J . The importance of the multidisciplinary approach to deal with the new epidemiological scenario of Chagas disease (global health). Acta Trop. 2015 Nov;151:16-20. doi: 10.1016/j.actatropica.2015.06.013.

Cambronero-Cortinas E. Epidemiology of Chagas Disease in Non-Endemic European Countries. International Cardiovascular Forum Journal. 2016;7:xx-xx. DOI: 10.17987/icfj.v7i0.353

Rodríguez-Zanella H, Salas Pacheco J, Meléndez-Ramirez G, et al. Advanced Imaging in Chagas Heart Disease: from diagnosis to sudden death risk stratification. International Cardiovascular Forum Journal. 2016;7:xx-xx. DOI: 10.17987/icfj.v7i0.225

Rivero CV and Roman PS. Drugs for the etiologic treatment of Chagas disease: Myths and Truths. International Cardiovascular Forum Journal. 2016;7:xx-xx. DOI: 10.17987/icfj.v7i0.351

Bern C. Chagas’ Disease. N Engl J Med 2015; 373: 456-66.

Guía para el equipo de salud Nro. 7ISSN 1852-1819 Dirección de Epidemiología - Ministerio de Salud de la Nación Av. 9 de Julio 1925 (C1073ABA), Cdad. Autónoma de Bs. As., República ArgentinaTeléfono: (54-11) 4379-9000 / Web: Impresión: Agosto/2010.

R. Viotti , B. Alarcón de Noya T. Araujo-Jorge, M. J. Grijalva, F. Guhl,e M. C. López, J. M. Ramsey,g I. Ribeiro, A. G. Schijman,iS. Sosa-Estani, F. Torrico, J. Gascon, on behalf of the Latin American Network for Chagas Disease, NHEPACHA; Towards a Paradigm Shift in the Treatment of Chronic Chagas Disease. Antimicrobial Agents and Chemotherapy; 2014, 58 (2), 635–639.

Di Toro D and Baranchuk A. Sudden cardiac death in Chagas disease. International Cardiovascular Forum Journal. 2016;vol:7:XX-XX. DOI 10.17987/icfj.v7i0.302

Rassi A Jr, Rassi SG, Rassi A. Sudden Death in Chagas ‘disease. Arq. Bras. Cardiol.2001 vol.76 n.1 São Paulo

Bestetti RB, Daniel RAF. The treatment of chronic heart failure secondary to Chagas cardiomyopathy in the contemporary era. International Cardiovascular Forum Journal. 2016;vol:7:XX-XX. DOI: 10.17987/icfj.v7i0.217

Shewan LG, Coats AJS, Henein M. Requirements for ethical publishing in biomedical journals. International Cardiovascular Forum Journal 2015;2:2 DOI: 10.17987/icfj.v2i1.4


Copyright (c) 2016 Louise Gabrielle Shewan, Andrew Coats, Michael Henein, Reinaldo Bestetti

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.